Bitterman Robert J 4
4 · Phio Pharmaceuticals Corp. · Filed Jun 11, 2024
Insider Transaction Report
Form 4
Bitterman Robert J
DirectorChairman, Pres. & CEO
Transactions
- Purchase
Common stock, $0.0001 par value
2024-06-07$0.74/sh+1,000$740→ 20,990 total
Footnotes (1)
- [F1]Includes shares of common stock underlying unvested restricted stock units.